HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,297-1,308 of 4,505
Drug study icon
CompletedNCT03503318

TV-46000 for schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of TV-46000 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 13–65
Countries
United States, Bulgaria
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Drug study icon
CompletedNCT04010305

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

Official study title

A Phase Ib Multicenter, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Determine Efficacy, Pharmacokinetics and Safety of BXCL501 in Agitation Associated With Schizophrenia

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Behavioral study icon
CompletedNCT06007105

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

Official study title

SUCCEED Africa: Protocol for a Multi-method Pilot Study of a Community-based Intervention for People With Psychosis in West and Southeast Africa

This study has finished and is no longer accepting participants.

Multiple locations, including Blantyre
Schizophrenia, Depression, ...Behavioural studyAges 18+
Countries
Malawi, Nigeria, Sierra Leone, + 1 other
Sponsor
London School of Hygiene and Tropical Medicine
Drug study icon
CompletedNCT07477301

Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia

Official study title

Supportive Psychotherapy As An Adjunct To Risperidone Improves Cognitive Function And Reduces High-Sensitivity C-Reactive Protein (Hs-CRP) In Schizophrenia: A Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Makassar
SchizophreniaMedication studyAges 20–45
Countries
Indonesia
Sponsor
Hasanuddin University
Device study icon
CompletedNCT03217357

tDCS, Stress and Risk for Schizophrenia

Official study title

Effects of Transcranial Direct Current Stimulation on Stress Reactivity and Decision Making in Unaffected Siblings of Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Bron
SchizophreniaDevice studyAges 18–30
Countries
France
Sponsor
Hôpital le Vinatier
Drug study icon
TerminatedNCT03868839

Telmisartan Study on Treatment Resistant Schizophrenia

Official study title

An Open-label Feasibility Trial of Adjunctive Telmisartan in Patients With Treatment Resistant Schizophrenia

This study ended early.

In Worcester
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Xiaoduo Fan
Behavioral study icon
CompletedNCT02150174

Testing Effect and Schizophrenia

Official study title

Retrieval Practice in Patients With Schizophrenia : an Exploratory Study Using Word Pairs

This study has finished and is no longer accepting participants.

Multiple locations, including Laxou
SchizophreniaBehavioural studyAges 18–60
Countries
France
Sponsor
University Hospital, Strasbourg, France
Other study type icon
Active Not RecruitingNCT07351240

The Acupuncture Treatment Effect in people with Schizophrenia

Official study title

The Quality of Life of Acupuncture Treatment Effect in Patients With Schizophrenia

This study is no longer accepting new participants.

In Pingtung City
SchizophreniaInterventional studyAges 20–65
Countries
Taiwan
Sponsor
Calo Psychiatric Center

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.